Here, our study performed both in vitro and in vivo investigations to determine the impact of indomethacin, a representative NSAID, against lupus using FcgRIIb-/- asymptomatic lupus mice at 24 wks old. This evidence concerns the gene FCGR2B and systemic lupus erythematosus.